Heterozygous Familial Hypercholesterolemia

被引：24
|
作者：
Onorato, Angela [1 ]
Sturm, Amy C. [2 ,3 ]
机构：
[1] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Wexner Med Ctr, Div Human Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
来源：
CIRCULATION | 2016年 / 133卷 / 14期
关键词：
HEART-ASSOCIATION; GUIDANCE;
D O I：
10.1161/CIRCULATIONAHA.115.020701
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E587 / E589
页数：3
相关论文
共 50 条
  • [21] Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
    Santos, Raul D.
    Ruzza, Andrea
    Hovingh, G. Kees
    Wiegman, Albert
    Mach, Francois
    Kurtz, Christopher E.
    Hamer, Andrew
    Bridges, Ian
    Bartuli, Andrea
    Bergeron, Jean
    Szamosi, Tamas
    Santra, Saikat
    Stefanutti, Claudia
    Descamps, Olivier S.
    Greber-Platzer, Susanne
    Luirink, Ilse
    Kastelein, John J. P.
    Gaudet, Daniel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14): : 1317 - 1327
  • [22] Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
    Raal, Frederick J.
    Kallend, David
    Ray, Kausik K.
    Turner, Traci
    Koenig, Wolfgang
    Wright, R. Scott
    Wijngaard, Peter L. J.
    Curcio, Danielle
    Jaros, Mark J.
    Leiter, Lawrence A.
    Kastelein, John J. P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1520 - 1530
  • [23] PROCEDURE FOR THE DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Benedi, Victoria Marco
    Gasso, Salvador Olmos
    Lagunas, Ana Cenarro
    Corredoira, Pablo Fernandez
    Sanz, Ana M. Bea
    Murillo, Fernando Civeira
    [J]. ATHEROSCLEROSIS, 2024, 395
  • [24] Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
    Santos, Raul D.
    Wiegman, Albert
    Caprio, Sonia
    Cariou, Bertrand
    Averna, Maurizio
    Poulouin, Yann
    Scemama, Michel
    Manvelian, Garen
    Garon, Genevieve
    Daniels, Stephen
    [J]. JAMA PEDIATRICS, 2024, 178 (03) : 283 - 293
  • [25] DIFFERENT PHENOTYPES IN SIBLINGS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kyselak, O.
    Soska, V.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E182 - E182
  • [26] Mortality from heterozygous familial hypercholesterolemia.
    Sijbrands, EJG
    Defesche, JC
    Lombardi, P
    Westendorp, RJG
    Smelt, AHM
    Kastelein, JJP
    [J]. CIRCULATION, 1996, 94 (08) : 4321 - 4321
  • [27] Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
    Civeira, F
    [J]. ATHEROSCLEROSIS, 2004, 173 (01) : 55 - 68
  • [28] Genetic screening for homozygous and heterozygous familial hypercholesterolemia
    Izar, Maria C.
    Machado, Valeria A.
    Fonseca, Francisco A.
    [J]. APPLICATION OF CLINICAL GENETICS, 2010, 3 : 147 - 157
  • [29] Lipoprotein(a) metabolism in patients with heterozygous familial hypercholesterolemia
    Parhofer, KG
    Ritter, MM
    Geiss, C
    Schwandt, P
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 146 - 146
  • [30] Clinical management of Heterozygous Familial Hypercholesterolemia (FH)
    Soran, H.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 41 - 41
12345